Prediction of Treatment Efficacy and Telaprevir-Resistant Variants after Triple Therapy in Patients Infected with Hepatitis C Virus Genotype 1

It is often difficult to predict the response to telaprevir-pegylated interferon (PEG-IFN)-ribavirin triple therapy and the appearance of telaprevir-resistant variants. The present study determined the predictive factors of a sustained virological response (SVR) to 12- or 24-week triple therapy (T12...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Akuta, Norio, Suzuki, Fumitaka, Fukushima, Taito, Kawamura, Yusuke, Sezaki, Hitomi, Suzuki, Yoshiyuki, Hosaka, Tetsuya, Kobayashi, Masahiro, Hara, Tasuku, Kobayashi, Mariko, Saitoh, Satoshi, Arase, Yasuji, Ikeda, Kenji, Kumada, Hiromitsu
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society for Microbiology 2013
Gaiak:
Virology
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3754631/
https://ncbi.nlm.nih.gov/pubmed/23784126
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JCM.01129-13
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak